Back to search

University of Thessaly (UTH)

Διερεύνηση παραγόντων κινδύνου μακροχρόνιων επιπλοκών της Πνευμονικής Εμβολής

Abstract

dc:description

Although pulmonary embolism (PE) is considered an acute disease, it requires chronic follow-up, especially in patients who experience chronic physical and/ or mental complications. Impaired health related quality of life (HRQoL) has been reported on these patients. However, the available instruments are not specific to PE. The management algorithm for acute PE is known, but we do not know much about the long-term effects of the disease. Among the issues reported by patients during their follow-up are the occurrence of persistent symptoms, reduced functionality, and emotional distress. The causes are found in the presence of hereditarian and acquired risk factors that lead to hypercoagulability, endothelial damage, and thrombus formation. The enzyme TAFI (Thrombin Activatable Fibrinolysis Inhibitor) is involved in thrombus stabilization. The aim of this doctoral dissertation is to investigate whether there are prognostic factors to be considered and to identify more easily patients at increased risk of developing long-term complications after PE. To assess the long-term effects of PE on quality of life, the Greek version of the Heart Quality of Life (Heart QoL) questionnaire and the Short Form 36 (SF-36) questionnaire were used. To assess fatigue after the PE episode, the FAS (Fatigue Assessment Scale) was used, and for long-term functional impairment, the PVFS (Post-VTE Functional Status Scale) was used. Additionally, the value of the TAFI enzyme was prospectively evaluated to investigate its correlation with clinical characteristics and the presence of symptoms. Patients with PE (with or without deep vein thrombosis) from the PE Outpatient Clinic of the University Hospital of Larissa participated in the study. The patients completed the Heart Quality of Life (HeartQoL), Short Form 36 (SF-36), and Fatigue Assessment Scale (FAS) questionnaires, and blood samples were taken for TAFI enzyme measurement during their follow-up from March 2022 to February 2024. The determination of TAFI concentrations was performed using the ELISA immunoassay method (Catalog No: MBS2500580). The study was conducted under the approval of the Ethics and Deontology Committee of the Department of Nursing of the University of Thessaly and received protocol number 489/11-03-2022. Part of the doctoral dissertation was funded by the Institute for the Study and Education on Thrombosis and Antithrombotic Therapy. A total of 100 patients with PE (63% were men) with a mean age of 56.97 ± 16.09 years participated, and the TAFI value was measured in 40 of them. During the assessment of the patients, 59% reported reduced functionality compared to their level of functionality before the diagnosis of PE. The mean value of the physical component summary of the SF-36 was 44.59 ± (13.90), while the mean value of the mental component summary was 43.59 ± (19.78). The mean value of the Heart QoL overall score was 2.15 (±0.82), the physical score was 2.17 (±0.86), and the emotional score was 2.09 (±1.03). Common prognostic factors for the overall and physical scores of the Heart QoL were MRC dyspnea scale, reduced functionality, and the presence of symptoms, while the CCI (Charlson Comorbidity Index) was also involved in the physical score. For the emotional score, bleeding and reduced functionality were prognostic factors. To test the reliability of the Heart QoL questionnaire, Cronbach’s alpha was calculated with a value of 0.947. To demonstrate internal consistency, internal correlations were performed, where all dimensions of the questionnaire were statistically significantly (positively) related to each other with values ranging from 0.337 to 0.949. A correlation with the sample size was performed, resulting in a moderate correlation in the overall (0.558) and physical (0.606) scores and a good correlation in the emotional score (0.871). All the above indicators demonstrated the good reliability and internal consistency of the questionnaire. Mean age (±SD) of TAFI patients assessed was 57 (±15.75) years. The mean value of the first blood draw (9-12 months after initial diagnosis) was 953.34 (±524.59) ng/mL, while the mean value of the second blood draw (15-18 months after initial diagnosis) was 602 (±599.15) ng/mL. Patients who reported the occurrence of bleeding had statistically significantly lower TAFI enzyme values compared to patients who did not bleed (616.27±95.56 vs. 1134.83±100.94, p=0.002). Furthermore, patients with pathological results on the ventilation/perfusion lung scan had statistically significantly higher TAFI enzyme values compared to those who underwent V/Q scan but did not have residual venous obstruction (1596.06±86.98 vs. 994.55±206.12, p=0.034).In conclusion, patients with PE exhibit impaired HRQoL during their follow-up after the acute episode, related to reduced functional capacity, the presence of persistent symptoms, and bleeding complications. The Heart QoL questionnaire demonstrates good internal consistency, reliability, and validity for use in patients with PE. The TAFI enzyme appears to be involved in the occurrence of bleeding and incomplete thrombus resolution; however, further research is needed.

Degree

thesis:*
Grantor dc:publisher
University of Thessaly (UTH)
Year dc:date
2025

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Gkena, Niki
  • Γκένα, Νίκη

Subjects

dc:subject × 10

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/58859

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Gkena, Niki; Γκένα, Νίκη. Διερεύνηση παραγόντων κινδύνου μακροχρόνιων επιπλοκών της Πνευμονικής Εμβολής. University of Thessaly (UTH), 2025. http://hdl.handle.net/10442/hedi/58859